REG - Craneware plc - Exercise of SAYE Options, Director Dealing & TVR

CranewareAnnouncement

01/11/2023 14:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231101:nRSA0859Sa&default-theme=true

RNS Number : 0859S  Craneware plc  01 November 2023

Craneware plc

("Craneware" or the "Company")

 

Exercise of SAYE Options, Director Dealing

and Total Voting Rights

 

1 November 2023 - The Board of Craneware plc (AIM: CRW.L), the market leader
in automated Value Cycle solutions for the US healthcare market, announces
that on 31 October 2023, options over ordinary shares of 1p each in the
Company ("Ordinary Shares") were exercised under the terms of the Craneware
plc SAYE Option Plan (2018) by certain employees and Directors (the "SAYE
Options" and together, the "Exercise").

 

Included within the Exercise was an aggregate of 3,136 SAYE Options exercised
by the following Directors:

 

 Director              Number of SAYE Options exercised  Exercise price         SAYE Options as a percentage of total voting rights of the Company

                                                         (per Ordinary Share)

 Keith Neilson (CEO)   1,568                             1,147.5 pence          0.004%

 Craig Preston (CFO)   1,568                             1,147.5 pence          0.004%

 

Following this transaction, Keith Neilson holds 3,467,707 Ordinary Shares,
representing 9.81% of the total voting rights of the Company and Craig Preston
holds 100,417 Ordinary Shares representing 0.28% of the total voting rights of
the Company, as described below.

 

Total Voting Rights

 

Following the Exercise and also the earlier exercise of SAYE Options and
receipt of employee vested share plan awards by certain other employees in the
period since 16 October 2023, the Company is transferring or has transferred a
total of 13,380 Ordinary Shares previously held in treasury to satisfy the
transactions. As a result, the Company's issued share capital now consists of
35,542,169 Ordinary Shares, of which 179,082 remain held in treasury.
Accordingly, the total number of Ordinary Shares in the Company with voting
rights is 35,363,087. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

 

PDMR notification: Keith Neilson

 

1.   Details of the Restricted Person / person closely associated with him
or her

a) Name
 
        Keith Neilson

 

2.   Reason for the notification

a) Position /
status
        CEO

b) Initial notification / Amendment
Initial notification

 

3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor

a)
Name
         Craneware plc

b)
LEI
         213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument
         Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification
code
         ISIN GB00B2425G68

 

c) Nature of the
transaction
Exercise of options over Ordinary Shares

 

d) Price(s) and volume(s)
                      Volume(s) 1,568 , Price(s) £11.475

 

e) Aggregated information:
         N/A (single transaction)

                                    i.
Aggregated volume             -

                                    ii.
Price(s)                              -

 

f) Date of the transaction
          2023-10-31

 

       g) Place of the transaction
                     Outside a trading venue

 

 

PDMR notification: Craig Preston

 

1.   Details of the Restricted Person / person closely associated with him
or her

a)
Name
Craig Preston

 

2.   Reason for the notification

a) Position /
status
CFO

b) Initial notification / Amendment               Initial
notification

 

3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor

a)
Name
Craneware plc

b)
LEI
213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument
Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification
code                                  ISIN
GB00B2425G68

 

c) Nature of the transaction
Exercise of options over Ordinary Shares

 

d) Price(s) and
volume(s)                            Volume(s)
1,568, Price(s) £11.475

 

e) Aggregated information:                         N/A
(single transaction)

                                    i.
Aggregated volume     -

                                    ii.
Price(s)                     -

 

f) Date of the transaction
2023-10-31

 

g) Place of the transaction
Outside a trading venue

 

 

 

For further information, please contact:

 

Craneware
plc
+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma (Financial
PR)
+44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara
Verdon
craneware@almastrategic.com

Peel Hunt (NOMAD and Joint Broker)
 
+44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers, Kate Bannatyne

Investec Bank PLC (Joint
Broker)
+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

About Craneware

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle
solutions, including 340B management, collaborates with U.S. healthcare
providers to plan, execute, and monitor operational and financial performance
so they can continue to deliver quality care to their communities. Customers
choose The Craneware  Group's Trisus data and applications platform as their
key to navigating the journey to financially sustainable  value-based care.
Trisus combines revenue integrity, cost management, 340B performance, and
decision enablement into a single, SaaS-based platform. Trisus Chargemaster
secured top ranking in the Chargemaster Management category of the "2023 Best
in KLAS Awards: Software & Services" and is part of an extensive value
cycle management suite. The Craneware Group - transforming the business of
healthcare.

 

Learn more at www.thecranewaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHNKDBNQBDDADK